docetaxel,rucaparib,abiraterone,enzalutamide
pfizer,astellas,clovis oncology
['rucaparib', 'brca', 'crpc', '#gu,(-#gui),(-#gunagratinib),(-#guard),(-#gut)', 'triton3']
triton3: rucaparib for mcrpc patients with brca or atm alteration. rpfs benefit compared with doce or abi/enza, without significant os improvement. intriguing data from several subgroup analysis. #gu23 
Medical Oncologist - Urologic Oncology. Hospital Universitario La Paz - IdiPAZ, Madrid